Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Surface Protein gp120 Market by Type (DS-003, BMD-104, HNG-156, M-48U1, Others), By Application (Hospital, Clinic, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Surface Protein gp120 Market by Type (DS-003, BMD-104, HNG-156, M-48U1, Others), By Application (Hospital, Clinic, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 309206 4200 Pharma & Healthcare 377 120 Pages 4.7 (46)
                                          

Market Overview:


The global surface protein gp120 market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of HIV/AIDS and rising demand for better treatment options. Based on type, the global surface protein gp120 market is segmented into DS-003, BMD-104, HNG-156, M-48U1 and others. DS-003 held the largest share of the global surface protein gp120 market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its high efficacy and safety profile. Based on application, hospital held the largest share of the global surface protein gp120 market in 2017 and is expected to maintain its dominance duringthe forecast period.


Global Surface Protein gp120 Industry Outlook


Product Definition:


gp120 is a glycoprotein found on the surface of the human immunodeficiency virus (HIV). It is important for HIV to attach to and enter cells, where it can then replicate. Drugs that block gp120 may be used to treat or prevent HIV infection.


DS-003:


The drug-like substance (DS-003) is a new drug with an innovative mechanism of action. It has been designed to treat patients infected with the HIV virus, which cannot be treated by current anti-retroviral drugs. DS-003 is currently under phase II clinical trials and expected to be commercialized in 2015.


BMD-104:


BD Bioscience is a leading developer of monoclonal antibodies and offers a wide range of products for research, diagnostics, and therapeutic applications. The company’s expertise covers an extensive range of antibody therapeutics including tumor-antigen targeting, immuno-oncology, immunotherapy & autoimmune disease therapy.


Application Insights:


Based on application, the global market has been segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. This is due to an increase in government funding for HIV/AIDS treatment coupled with rising awareness about the disease among individuals at high-risk. Moreover, a rise in new product approvals by prominent companies such as Merck & Co., Inc., Pfizer, Inc., and Johnson & Johnson is expected to drive demand over the forecast period.


The clinic segment was estimated to be worth USD 142 million in 2017 owing to an increase in spending on antiretroviral drugs that are used against AIDS infections among individuals who have sex with men as well as heterosexuals living with HIV infection without access to affordable treatment facilities or skilled personnel at low cost across major regions of the world including North America and Europe.


Regional Analysis:


North America dominated the global surface protein gp120 market in 2017. The presence of a large number of manufacturers and the introduction of novel products are some factors responsible for its largest share. In addition, increasing funding by government organizations is also expected to contribute towards regional growth over the forecast period. For instance, in March 2018, New York Blood Center announced about receiving a gift from Gilead Sciences Inc.


Asia Pacific is anticipated to grow at an exponential rate during the forecast period owing to various factors such as rising incidence of HIV/AIDS & cancer due to infection with surface protein gp120 variants coupled with growing R&D expenditure by pharmaceutical companies for developing new drugs targeting these proteins.


Growth Factors:


  • Increasing HIV/AIDS prevalence rates across the globe is expected to drive demand for surface protein gp120 over the forecast period.
  • Growing number of clinical trials for development of novel therapeutics is anticipated to propel market growth.
  • Rising investments by key players in R&D activities is likely to provide impetus to the market growth.
  • Technological advancements in detection and diagnosis of HIV infections are projected to boost demand for surface protein gp120 over the forecast period .

Scope Of The Report

Report Attributes

Report Details

Report Title

Surface Protein gp120 Market Research Report

By Type

DS-003, BMD-104, HNG-156, M-48U1, Others

By Application

Hospital, Clinic, Others

By Companies

GlaxoSmithKline Plc, Osel, Inc., Sanofi Pasteur SA, TeneoBio Inc, United Biomedical, Inc., ViiV Healthcare Limited, GlaxoSmithKline Plc

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

120

Number of Tables & Figures

84

Customization Available

Yes, the report can be customized as per your need.


Global Surface Protein gp120 Market Report Segments:

The global Surface Protein gp120 market is segmented on the basis of:

Types

DS-003, BMD-104, HNG-156, M-48U1, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Clinic, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GlaxoSmithKline Plc
  2. Osel, Inc.
  3. Sanofi Pasteur SA
  4. TeneoBio Inc
  5. United Biomedical, Inc.
  6. ViiV Healthcare Limited
  7. GlaxoSmithKline Plc

Global Surface Protein gp120 Market Overview


Highlights of The Surface Protein gp120 Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. DS-003
    2. BMD-104
    3. HNG-156
    4. M-48U1
    5. Others
  1. By Application:

    1. Hospital
    2. Clinic
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Surface Protein gp120 Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Surface Protein gp120 Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


gp120 is a protein that is found on the surface of HIV-1. It helps the virus attach to cells and spread through the body.

Some of the major players in the surface protein gp120 market are GlaxoSmithKline Plc, Osel, Inc., Sanofi Pasteur SA, TeneoBio Inc, United Biomedical, Inc., ViiV Healthcare Limited, GlaxoSmithKline Plc.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Surface Protein gp120 Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Surface Protein gp120 Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Surface Protein gp120 Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Surface Protein gp120 Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Surface Protein gp120 Market Size & Forecast, 2020-2028       4.5.1 Surface Protein gp120 Market Size and Y-o-Y Growth       4.5.2 Surface Protein gp120 Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 DS-003
      5.2.2 BMD-104
      5.2.3 HNG-156
      5.2.4 M-48U1
      5.2.5 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Clinic
      6.2.3 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Surface Protein gp120 Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Surface Protein gp120 Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 DS-003
      9.6.2 BMD-104
      9.6.3 HNG-156
      9.6.4 M-48U1
      9.6.5 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Clinic
      9.10.3 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 DS-003
      10.6.2 BMD-104
      10.6.3 HNG-156
      10.6.4 M-48U1
      10.6.5 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Clinic
      10.10.3 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 DS-003
      11.6.2 BMD-104
      11.6.3 HNG-156
      11.6.4 M-48U1
      11.6.5 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Clinic
      11.10.3 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 DS-003
      12.6.2 BMD-104
      12.6.3 HNG-156
      12.6.4 M-48U1
      12.6.5 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Clinic
      12.10.3 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 DS-003
      13.6.2 BMD-104
      13.6.3 HNG-156
      13.6.4 M-48U1
      13.6.5 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Clinic
      13.10.3 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Surface Protein gp120 Market: Competitive Dashboard
   14.2 Global Surface Protein gp120 Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 GlaxoSmithKline Plc
      14.3.2 Osel, Inc.
      14.3.3 Sanofi Pasteur SA
      14.3.4 TeneoBio Inc
      14.3.5 United Biomedical, Inc.
      14.3.6 ViiV Healthcare Limited
      14.3.7 GlaxoSmithKline Plc

Our Trusted Clients

Contact Us